Product Images Avodart

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Avodart NDC 69784-712 by Woodward Pharma Services Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Dutasteride structural formula - avodart spl image 01

Figure 1. AUA-SI Score* Change from Baseline (Randomized, Double-Blind, Placebo-Controlled Studies Pooled) - avodart spl image 02

Figure 2. Percent of Subjects Developing Acute Urinary Retention Over a 24-Month Period (Randomized, Double-Blind, Placebo-Controlled Studies Pooled) - avodart spl image 03

This appears to be a statistical report on a clinical trial, comparing a placebo group to a group taking a medication called Dutasteride. The data appears to show the number of events (presumably adverse events or negative outcomes) over a 6-12 month period, as well as the number of patients in each group at risk. Without further context or information, it is difficult to provide a more specific understanding of the report.*

Figure 3. Percent of Subjects Having Surgery for Benign Prostatic Hyperplasia Over a 24-Month Period (Randomized, Double-Blind, Placebo-Controlled Studies Pooled) - avodart spl image 04

Figure 4. Prostate Volume Percent Change from Baseline (Randomized, Double-Blind, Placebo-Controlled Studies Pooled) - avodart spl image 05

Figure 5. Qmax Change from Baseline (Randomized, Double-Blind, Placebo-Controlled Studies Pooled) - avodart spl image 06

This table provides information on the mean change from baseline (mLisec) in a clinical trial that evaluated the effectiveness of Dutasteride compared to a placebo. The data is organized by months of treatment and shows the number of participants (n) in each group.*

Figure 6. - avodart spl image 07

This is a table showing the number of months of treatment for two medications: dutasteride + tamsulosin and dutasteride alone or tamsulosin alone. The number of patients who received these medications is also given, but it is unclear what condition they were being treated for.*

Figure 7. Q-max Change Ffrom Baseline Over a 24-Month Period (Randomized, Double-Blind, Parallel Group Study [CombAT Study]) - avodart spl image 08

This is a graph showing the mean change from baseline (in ml/sec) over a period of 2 months of treatment with Dutasteride and Tamsulosin, Dutasteride alone and Tamsulosin alone. The y-axis shows the ml/sec, while the x-axis shows the months of treatment. However, without additional context or information on what this graph is measuring, it is difficult to provide a more detailed description.*

Avodart 0.5 mg 90 count label - avodart spl image 09

AVODART is a medication available in soft gelatin capsules of 0.5mg strength with NDC 6978471204. The manufacturer of this medication is not clearly stated, but the address for Mendoarad WoodadFhema is provided. The lot number for the capsules is ALB-1049 and it should not be used after 05/22. The rest of the text is not readable.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.